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Abstract
Background: The prevalence of Old World Cutaneous Leishmaniasis in the Mediterranean region is increasing and
in Southern Europe often caused by Leishmania infantum. Spontaneous healing of cutaneous leishmaniasis is
commonly observed, especially if caused by L. major, whereas L. infantum associated lesions have been reported
with longer disease duration and decreased tendency for self-limitation, however, available information is sparse.
Case presentation: We report the case of an otherwise healthy woman from Southern Spain who presented with
a seven years persistent, non-healing, painless, central ulcerated, nodular cutaneous lesion with a diameter of 2 cm
of the forearm. Cutaneous leishmaniasis was diagnosed by smear and histology, showing large amounts of leishmania
amastigotes in subepidermal histiocytes and extensive lymphocyte and plasma cell inflammation. L. infantum as
the causative pathogen was confirmed by restriction fragment length polymorphism and microsatellite-PCR.
Systemic or visceral involvement was excluded by negative leishmania serology and clinical presentation, relevant
concomitant diseases or immunosuppression were excluded including quantification of immunoglobulin levels and
lymphocyte phenotyping. Topical and systemic anti-infectious treatment options, often limited in terms of efficacy,
tolerability and long lasting treatment duration, were considered. Treatment was successfully performed by surgical
extraction in local anaesthesia only.
Conclusion: To our knowledge this is the longest reported duration of a L. infantum associated cutaneous
leishmaniasis indicating a potential long lasting natural evolution of the disease in an otherwise healthy and
immunocompetent patient, however, high parasite density may have reflected a lack of a L. infantum specific immune
response. Complete surgical extraction can be successfully performed as treatment.
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Background
The prevalence of cutaneous leishmaniasis (CL) in the
Mediterranean region is increasing and the variety of
causative leishmania species is diversifying possibly due
to worldwide travel and migration, increase of animal
reservoirs, and climate change favouring the spread
of the phlebotomine sandfly vectors [1]. Mediterranean
Old World CL (OWCL) can be caused by three different
Leishmania species. In Europe, CL is usually associated
with zoonotic Leishmania infantum infection with do-
mestic dogs as a main reservoir. CL caused by anthropo-
notic L. tropica is common in Western and Southern
Asia and has been reported from Greece but not from
other parts of Europe [1,2]. L. major infection has a
zoonotic reservoir in rodents and is absent in Europe
but a common cause of OWCL in North Africa, Middle
East and some regions in Subsaharan Africa [1]. High
prevalence rates of L. infantum in asymptomatic human
carriers from Southern Europe indicate that the disease
might be of greater public health relevance [3] as L.
infantum can also lead to life threatening visceral leish-
maniasis (VL) especially in individuals with underlying
immunosuppression such as patients with HIV infection.
Spontaneous healing of OWCL is commonly observed
after several months, especially if caused by L. major
[1,2,4], and has been associated in animal models with
the development of specific T helper cell Th1 immune
responses [5]. L. infantum associated OWCL seems to
have longer disease duration associated with a decreased
tendency for self-limitation, however, available informa-
tion is sparse.
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Case presentation
We report the case of a 35 year-old female who pre-
sented in January 2013 with a single painless, erythema-
tous, central ulcerated, nodular lesion with a diameter of
approximately 2 cm on her left forearm (Figure 1a). The
patient has a Moroccan family background, but was
born and grew up in Germany, and moved in 2006 to
the region of Granada in Spain. Within the same year a
cutaneous lesion started to appear as an erythematous
spot which developed over the following seven years to
the current presentation in the absence of systemic
symptoms such as fever, weight loss or fatigue. Various
topical treatments were without significant effect, swab
cultures from the ulcer showed only bacteria of the
normal skin flora. We could confirm the diagnosis of
OWCL from a small biopsy sample by positive smears
(Figure 1b), and histology revealed large amounts of
leishmania amastigotes in subepidermal histiocytes and
extensive lymphocyte and plasma cell inflammation
(Figure 1c and d). PCR diagnostic showed a restriction
fragment length polymorphism (RFLP) pattern of L.
donovani/L. infantum complex in an in-house assay [6].
Further differentiation was performed at a German ref-
erence center (Dr. Gabriele Schönian, Institute of Micro-
biology and Hygiene, Humboldt University, Charité,
Berlin) using microsatellite-PCR (Marker LIST7039) [7]
confirming L. infantum as the causative pathogen. Systemic
involvement or visceral leishmaniasis was excluded by
negative serological markers (ELISA, IFT, immunoblot)
using L. infantum as antigen, absence of systemic clin-
ical symptoms including absence of lymphadenopathy
or hepatosplenomegaly in ultrasound diagnostic. Con-
comitant disease or immunosuppression were excluded
by laboratory parameters including normal values for
haematology, clinical organ chemistry, plasma protein
and quantitative immunoglobulin levels, normal abso-
lute and relative values in lymphocyte phenotyping for
T-cell, B-cell and NK cell populations, negative sero-
logical testing for HIV, syphilis, hepatitis B and C. No
other skin lesions were present, sandfly exposure and
family history of similar lesions was not obtained. Al-
though, the patient regularly travelled to Morocco the
infection was probably acquired in Spain since the last
travel to Morocco had been more than 1 year before
onset
After a thorough discussion with the patient about
therapeutic alternatives such as cryotherapy, topical an-
timony therapy, or systemic chemotherapy, it was de-
cided to perform a total excision of the lesion in local
anaesthesia, taking into consideration its small size and
long duration as well as an imminent business trip of
the patient. Follow-up visits after 11 months showed
complete healing with a minimal residual scar.
Conclusion
This case represents to our knowledge the longest re-
ported duration with seven years persistence of a L.
infantum CL indicating a potential long lasting natural
evolution of the disease in an otherwise healthy and im-
munocompetent patient. OWCL caused by L. major usually
heal within 2–8 months, and lesions in L. tropica infection
often heal spontaneously within one year [4]. Cases of
Figure 1 Clinical presentation and histology of the Leishmania lesion. (a) Ulcerated, nodular lesion on the left forearm, (b) Leishmania
amastigotes in a biopsy smear (Giemsa stain), (c) excised ulcer with subepidermal lymphocyte and plasma cell inflammation (HE stain), (d) large
amounts of Leishmania amastigotes in histiocytes (Giemsa stain).
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chronic, non-healing cutaneous or mucocutaneous leish-
manisis caused by L. infantum have been reported mostly
in patients with HIV or immunosuppressive treatments, or
in patients with atypical clinical presentations such as re-
lapsing CL, leishmaniasis recidivans (LR) or mucosal locali-
zations [8,9]. A maximum duration until spontaneous
healing of up to 3 years has been reported for typical L.
infantum OWCL lesions in immunocompetent patients
[9]. In Turkey, Cukurova region, a CL focus initially linked
to L. infantum by PCR-RFLP, transmitted by Phlebotomus
tobbi was described and patients presented mostly with
small, non-ulcerative lesions which lasted for at least 2 years
with only few cases of spontaneous healing [10]. As in our
case negative leishmania serology was seen in these patients
which is probably typical for CL cases caused by L. infan-
tum. Recently the causative Leishmania strain from this re-
gion was revealed by whole genome sequencing as a
natural hybrid between L. infantum and L. donovani [11],
indicating that diagnostic molecular methods might have
some limitation for species differentiation. Unfortunately,
we were not able to isolate the parasite in our case into cul-
ture for further specification and origin detection.
As reviewed by Peters and Sacks [5] chronic or pro-
gressive leishmaniasis has been associated by the para-
site’s ability to evade macrophage defense mechanism
such as killing by oxygen-derived free radicals, to produce
defects in the induction and expression of cell-mediated
immune mechanisms such as suboptimal T-cell receptor
(TCR) signaling and the inability of Leishmania-infected
macrophages to produce IL-12 as the main inducer of IFN-
y and CD4+ T cell Th1 differentiation resulting in defected
cellular immune response. Furthermore it was speculated
that the regulation of adaptive immune responses by
CD25 + Foxp3+ T regulatory cells in the skin downregulate
parasite-specific immunity allowing Leishmania species to
establish chronic infection. It is speculative if such mechan-
ism applied in our case, either caused by the host’s local im-
mune characteristics or special phenotypic properties of the
parasite itself – such as the hybrid strain from the Cukur-
ova region - evading immune control. Lack of immune
control in our case might be supported by high parasite
density seen in histology and smear.
For OWCL, several topical and systemic treatment op-
tions are available. However, all have substantial limitations
in terms of efficacy and tolerability [4]. For L. infantum CL
there are currently no randomized, placebo-controlled
treatment studies available to guide treatment decision.
Small observational studies and case reports have described
treatment success with intralesional antimonials, cryother-
apy or oral triazole antifungals [12-14]. Other systemic
treatment options such as pentavalent antimony, pentami-
dine, amphotericin B or miltefosine should be reserved for
complex or complicated disease because of the risk of sig-
nificant toxicity. In uncomplicated OWCL presenting as a
single lesion of limited size (<4 cm of diameter) surgical ex-
cision has also been applied successfully [15], which was
also confirmed in our case.
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